Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Cushings Syndrome Market Overview, Regional Analysis and Competitive Landscape

Cushing's syndrome is characterised by high blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat hump between the shoulders, and fragile skin that heals slowly as a result of extended cortisol exposure. Cushing's syndrome is caused by two main factors: excessive cortisol-like medicines, such as prednisone, and tumours generated by adrenal glands overproducing cortisol. Other tumours, such as those associated with hereditary illnesses such multiple endocrine neoplasia type 1 and Carney complex, may also cause this condition. In most situations, a combination of surgery, radiation, and chemotherapy can be used to treat and cure the cancer.

Intake of glucocorticoids recommended by a healthcare professional to treat other disorders such as asthma, rheumatoid arthritis, or immunosuppression following an organ transplant is the most common cause of Cushing's syndrome. The disease can also be caused by the use of synthetic ACTH. Other animals, such as cats, dogs, and horses, may also be affected. All of the aforementioned causes are projected to boost the Cushing's syndrome market.


Cushing’s Syndrome Market- Regional Analysis

Cushing's syndrome is divided into five regions: North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa. The presence of a high income standard and a high level of health awareness in North America encourages the expansion of the market for Cushing's syndrome. Obesity is a primary cause of Cushing's syndrome, according to the Centers for Disease Control and Prevention, with 36.5 percent of individuals in the United States having it between 2011 and 2014. Furthermore, according to the American Diabetes Association, African Americans, Latin Americans, and Asian Pacific Islanders are the most likely to develop type 2 diabetes.

 

Cushings Syndrome Market
Cushings Syndrome Market

Cushing’s Syndrome Market- Competitive Landscape

Increased research and development in 2016, like Strongbrigde Biopharma plc's development of clinical trials for RECORLEV for the treatment of endogenous Cushing's syndrome, is expected to increase competition and favour growth among manufacturers to lead the market. Corcept Therapeutics Inc., HRA Pharma, Strongbridge Biopharma plc., and Novartis AG are among the leading companies in the Cushing's syndrome industry.

Comments

Popular posts from this blog

Optical Brighteners Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

Dental Filling material Market: Region Wise Outlook and Drive growth

Future Prospects of Global Laboratory Proficiency Testing Market